Vol.

No.

January 11, 2019Jan 11, 2019

DOWNLOAD THE PDF

John Mendelsohn, translational researcher who led MD Anderson for 15 years, dies at 82

Cover Story

Free

John Mendelsohn, translational researcher who led MD Anderson for 15 years, dies at 82

John Mendelsohn, president emeritus of MD Anderson Cancer Center and an elder statesman in oncology, died Jan. 7 at his home in Houston. He was 82.

Free Obituary

John Mendelsohn understood the urgency of moving discoveries out of the laboratory and into patients

By Margaret L. Kripke

Free Obituary

John Mendelsohn knew the science. He knew the medicine. He enlisted people to invest in curing and treating cancer

By Raymond N. DuBois

Letter To The Editor

The Waun Ki Hong we knew and admired

By Irwin H. Krakoff

NCI advisors approve 7 concepts, including 2 Moonshot concepts

By Claire Dietz

In Brief

José Baselga heads to AstraZeneca amid organizational changes

Cindy Perettie named as chief executive officer of Foundation Medicine

Lori Hazlehurst named as WVU Cancer Institute associate director

Lilly to acquire Loxo Oncology

Nanobiotix, MD Anderson form clinical collaboration on NBTXR3

Adaptive Biotechnologies, Genentech form collaboration and license agreement

Maureen Testoni named 340B Health CEO

Funding Opportunities

DOD Breast Cancer Research Program publishes awards information

Clinical Roundup

NCI's BRCA Exchange aggregates data on BRCA variants to inform understanding of risk

ASCO publishes standards for handling of hazardous drugs

AI outperformed human experts in identifying cervical precancer

UroGen announces positive results of UGN-101 from phase III trial in urothelial cancer

Cancer rates are dropping, but socioeconomic inequalities widen

Drugs & Targets

Gottlieb warns FDA has about one month of user fee funds left

FDA to “take action” against branded drug makers using scare tactics to thwart biosimilar competition

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 51 | Issue 42 - November 14, 2025